Howard S. Jonas Buys 13,080,457 Shares of Rafael Holdings, Inc. (NYSE:RFL) Stock

Rafael Holdings, Inc. (NYSE:RFL) CEO Howard S. Jonas purchased 13,080,457 shares of the stock in a transaction dated Thursday, June 5th. The shares were purchased at an average cost of $1.28 per share, for a total transaction of $16,742,984.96. Following the transaction, the chief executive officer now owns 12,299,207 shares in the company, valued at approximately $15,742,984.96. The trade was a -1,674.30% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.

Rafael Trading Up 26.2%

Shares of RFL stock opened at $2.84 on Wednesday. The company’s 50-day moving average price is $1.58 and its 200-day moving average price is $1.80. The stock has a market cap of $70.75 million, a price-to-earnings ratio of -1.70 and a beta of 0.91. Rafael Holdings, Inc. has a twelve month low of $1.28 and a twelve month high of $3.19.

Rafael (NYSE:RFL) last announced its quarterly earnings results on Thursday, March 13th. The company reported ($0.06) earnings per share for the quarter. The firm had revenue of $0.08 million for the quarter. Rafael had a negative net margin of 5,707.03% and a negative return on equity of 53.71%.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently modified their holdings of RFL. Peapod Lane Capital LLC acquired a new position in Rafael in the fourth quarter valued at about $553,000. Geode Capital Management LLC raised its stake in shares of Rafael by 17.9% in the 4th quarter. Geode Capital Management LLC now owns 174,561 shares of the company’s stock valued at $288,000 after acquiring an additional 26,493 shares during the period. Wealth Enhancement Advisory Services LLC acquired a new position in shares of Rafael in the 1st quarter worth approximately $26,000. Finally, Ieq Capital LLC acquired a new position in shares of Rafael in the 1st quarter worth approximately $447,000. Institutional investors and hedge funds own 11.30% of the company’s stock.

About Rafael

Rafael Holdings, Inc primarily engages in holding interests in clinical and early-stage pharmaceutical companies, and commercial real estate assets in the United States and Israel. It operates in two segments, Healthcare and Real Estate. The company engages in the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells.